Achievements and Perspectives
暂无分享,去创建一个
Jean Falcimaigne | J. Brac | Y. Charron | Philippe Pagnier | Regis Vilagines | Y. Charron | R. Vilagines | J. Falcimaigne | J. Brac | P. Pagnier
[1] A. Waterhouse,et al. Analysis of pigmented high-molecular-mass grape phenolics using ion-pair, normal-phase high-performance liquid chromatography. , 2000, Journal of chromatography. A.
[2] Craig W. Reynolds,et al. In vivo role of natural killer cells: involvement of large granular lymphocytes in the clearance of tumor cells in anti-asialo GM1-treated rats. , 1983, Journal of immunology.
[3] C. Thompson,et al. CD28 costimulation prevents cell death during primary T cell activation. , 1996, Journal of immunology.
[4] R. Schofield. The relationship between the spleen colony-forming cell and the haemopoietic stem cell. , 1978, Blood cells.
[5] L. E. Bakken,et al. Gullfaks Multiphase Booster Project , 1995 .
[6] A. Friedenstein,et al. STROMAL CELLS RESPONSIBLE FOR TRANSFERRING THE MICROENVIRONMENT OF THE HEMOPOIETIC TISSUES: Cloning In Vitro and Retransplantation In Vivo , 1974, Transplantation.
[7] Y. Glories,et al. Determination of the Composition of Commercial Tannin Extracts by Liquid Secondary Ion Mass Spectrometry (LSIMS) , 1996 .
[8] M P Arnaudeau. DEVELOPMENT OF A TWO-PHASE OIL PUMPING SYSTEM FOR EVACUATING SUBSEA PRODUCTION WITHOUT PROCESSING OVER A LONG DISTANCE: POSEIDON PROJECT , 1988 .
[9] R. Steinman,et al. Proliferating dendritic cell progenitors in human blood , 1994, The Journal of experimental medicine.
[10] S. Casares,et al. Generation of LAK cells in vitro in patients with acute leukemia. , 1993, Leukemia.
[11] C. Bieberich,et al. Role of the major histocompatibility complex class I antigens in tumor growth and metastasis. , 1988, Annual review of immunology.
[12] J. Tikerpae,et al. Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow. , 1992, Journal of immunology.
[13] R. Arceci,et al. Irradiated B7-1 transduced primary acute myelogenous leukemia (AML) cells can be used as therapeutic vaccines in murine AML. , 1996, Blood.
[14] M. Chien,et al. Characterization of grape procyanidins using high-performance liquid Chromatography/Mass spectrometry and matrix-assisted laser Desorption/Ionization time-of-flight mass spectrometry. , 2000, Journal of agricultural and food chemistry.
[15] J. Triffitt,et al. Adipocytic cells cultured from marrow have osteogenic potential. , 1991, Journal of cell science.
[16] F. Aversa,et al. Successful engraftment of T-cell-depleted haploidentical "three-loci" incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum. , 1994, Blood.
[17] H. Heslop,et al. Adoptive cellular immunotherapy for EBV lymphoproliferative diseases , 1997 .
[18] A. Tosti,et al. Natural killer (NK)-cell function and antileukemic activity of a large population of CD3+/CD8+ T cells expressing NK receptors for major histocompatibility complex class I after "three-loci" HLA-incompatible bone marrow transplantation. , 1996, Blood.
[19] S. Guyot,et al. Methods for Determining the Degree of Polymerization of Condensed Tannins: A New 1H-NMR Procedure Applied to Cider Apple Procyanidins , 1999 .
[20] D. Blaise,et al. Consolidation treatment of adult acute lymphoblastic leukemia: a prospective, randomized trial comparing allogeneic versus autologous bone marrow transplantation and testing the impact of recombinant interleukin-2 after autologous bone marrow transplantation. BGMT Group. , 1995, Blood.
[21] M. Herderich,et al. Characterization of proanthocyanidins in grape seeds using electrospray mass spectrometry. , 2003, Rapid communications in mass spectrometry : RCM.
[22] Lieping Chen,et al. Can Co‐stimulated Tumor Immunity be Therapeutically Efficacious? , 1995, Immunological reviews.
[23] M. Scott,et al. IN SEARCH OF THE HAEMOPOIETIC STEM CELL , 1995, British journal of haematology.
[24] J. Glowacki,et al. Engraftment of a clonal bone marrow stromal cell line in vivo stimulates hematopoietic recovery from total body irradiation. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[25] P. Greenberg,et al. Isolation of Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes that lyse Reed-Sternberg cells: implications for immune-mediated therapy of EBV+ Hodgkin's disease. , 1997, Blood.
[26] E. Archimbaud,et al. Inducibility of lymphokine activated killer (LAK) cells in patients with acute myelogenous leukaemia in complete remission and its clinical relevance , 1991, British journal of haematology.
[27] L. Chen,et al. Costimulation by CD48 and B7-1 induces immunity against poorly immunogenic tumors , 1996, The Journal of experimental medicine.
[28] Craig W. Reynolds,et al. Ganciclovir treatment of herpes simplex thymidine kinase-transduced primary T lymphocytes: an approach for specific in vivo donor T-cell depletion after bone marrow transplantation? , 1994, Blood.
[29] S. Rosenberg,et al. Lymphokine-activated killer (LAK) cell phenomenon. IV. Lysis by LAK cell clones of fresh human tumor cells from autologous and multiple allogeneic tumors. , 1985, Journal of the National Cancer Institute.
[30] James M. Wilson,et al. CD40 Ligand-Dependent T Cell Activation: Requirement of B7-CD28 Signaling Through CD40 , 1996, Science.
[31] J. Dick,et al. Differential Maintenance of Primitive Human SCID-Repopulating Cells, Clonogenic Progenitors, and Long-Term Culture-Initiating Cells After Incubation on Human Bone Marrow Stromal Cells , 1997 .
[32] B. G. Chan,et al. The conversion of procyanidins and prodelphinidins to cyanidin and delphinidin , 1985 .
[33] M. Moore,et al. Expansion of immunostimulatory dendritic cells among the myeloid progeny of human CD34+ bone marrow precursors cultured with c-kit ligand, granulocyte-macrophage colony-stimulating factor, and TNF-alpha. , 1995, Journal of immunology.
[34] D. Leavesley,et al. Potential adhesion mechanisms for localisation of haemopoietic progenitors to bone marrow stroma. , 1994, Leukemia & lymphoma.
[35] C. Nagel,et al. Changes in the Anthocyanins, Flavonoids and Hydroxycinnamic Acid Esters during Fermentation and Aging of Merlot and Cabernet Sauvignon , 1979, American Journal of Enology and Viticulture.
[36] J. Mayordomo,et al. Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity , 1996, The Journal of experimental medicine.
[37] V. Kováč,et al. The Effect of Adding Supplementary Quantities of Seeds During Fermentation on the Phenolic Composition of Wines , 1995, American Journal of Enology and Viticulture.
[38] S. Rosenberg,et al. Separation and functional studies of the human lymphokine-activated killer cell. , 1987, Cancer research.
[39] C. Nagel,et al. High-Pressure Liquid Chromatographic Separation of Anthocyanins of Vitis Vinifera , 1978, American Journal of Enology and Viticulture.
[40] L. Zitvogel,et al. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity , 1995, Nature Medicine.
[41] P. Musiani,et al. Cytokine-induced tumor immunogenicity: from exogenous cytokines to gene therapy. , 1993, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.
[42] V. Cheynier,et al. 2D NMR analysis for unambiguous structural elucidation of phenolic compounds formed through reaction between (+)‐catechin and glyoxylic acid , 2002 .
[43] M. Bourzeix,et al. Separation and quantitative determination of grape and wine procyanidins by high performance reversed phase liquid chromatography , 1990 .
[44] J. Gribben,et al. Complete blockade of B7 family-mediated costimulation is necessary to induce human alloantigen-specific anergy: a method to ameliorate graft-versus-host disease and extend the donor pool. , 1996, Blood.
[45] A. Chang,et al. Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. , 1985, The New England journal of medicine.
[46] J. Falkenburg,et al. Generation of CD4+ cytotoxic T-lymphocyte clones from a patient with severe graft-versus-host disease after allogeneic bone marrow transplantation: implications for graft-versus-leukemia reactivity. , 1995, Blood.
[47] G. Almeida-Porada,et al. THE ROLE OF SHEEP STROMA IN HUMAN HAEMOPOIESIS IN THE HUMAN/SHEEP CHIMAERAS , 1996, British journal of haematology.
[48] J. Ritz,et al. Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF , 1992, The Journal of experimental medicine.
[49] V. Cheynier,et al. Quantitative fractionation of grape proanthocyanidins according to their degree of polymerization. , 1999, Journal of agricultural and food chemistry.
[50] C. Rooney,et al. Adenovirus-pulsed dendritic cells stimulate human virus-specific T-cell responses in vitro , 1996, Journal of virology.
[51] S. Guyot,et al. ESI-MS analysis of polyphenolic oligomers and polymers : New methods for analysing old plant polyphenols , 1997 .
[52] S. Fosså,et al. Interleukin-2 with or without LAK cells in metastatic renal cell carcinoma: a report of a European multicentre study. , 1989, European journal of cancer & clinical oncology.
[53] Yumiko Nakamura,et al. Analysis of Proanthocyanidins in Grape Seed Extracts, Health Foods and Grape Seed Oils , 2003 .
[54] G. Hale,et al. Risks of developing Epstein-Barr virus-related lymphoproliferative disorders after T-cell-depleted marrow transplants. CAMPATH Users. , 1998, Blood.
[55] J. Miller,et al. CD56+bright and CD56+dim natural killer cells in patients with chronic myelogenous leukemia progressively decrease in number, respond less to stimuli that recruit clonogenic natural killer cells, and exhibit decreased proliferation on a per cell basis. , 1996, Blood.
[56] N. Romani,et al. High Level IL-12 Product ion by Murine Dendrit ic Cells : Upregulation via MHC Class II and CD 40 Molecules and Downregulat ion by IL-4 and IL-10 By , 2003 .
[57] P. Linsley,et al. Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4 , 1992, Cell.
[58] K. Lucas,et al. Biology and adoptive cell therapy of Epstein‐Barr virus‐associated lymphoproliferative disorders in recipients of marrow allografts , 1997, Immunological reviews.
[59] Malcolm K. Brenner,et al. Long–term restoration of immunity against Epstein–Barr virus infection by adoptive transfer of gene–modified virus–specific T lymphocytes , 1996, Nature Medicine.
[60] K. Tamada,et al. The involvement of transforming growth factor beta in the impaired antitumor T-cell response at the gut-associated lymphoid tissue (GALT). , 1995, Cancer research.
[61] Y. Glories,et al. Composition and cellular localization of tannins in grape seeds during maturation. , 2003, Journal of agricultural and food chemistry.
[62] J. Yewdell,et al. Identification of human cancers deficient in antigen processing , 1993, The Journal of experimental medicine.
[63] C. Janeway,et al. Signals and signs for lymphocyte responses , 1994, Cell.
[64] Stephen P. Schoenberger,et al. T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions , 1998, Nature.
[65] M. Moser,et al. Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo , 1994, European journal of immunology.
[66] K. Parker,et al. Targeted T-cell therapy for human leukemia: cytotoxic T lymphocytes specific for a peptide derived from proteinase 3 preferentially lyse human myeloid leukemia cells. , 1996, Blood.
[67] M. El Hajem,et al. Exploration par anémométrie laser Doppler de l'écoulement dans une pompe hélico-axiale , 2001 .
[68] J. Miller,et al. Differentiation of natural killer (NK) cells from human primitive marrow progenitors in a stroma-based long-term culture system: identification of a CD34+7+ NK progenitor. , 1994, Blood.
[69] C. Verfaillie,et al. Adherent lymphokine-activated killer cells in chronic myelogenous leukemia: a benign cell population with potent cytotoxic activity. , 1989, Blood.
[70] L. Adorini,et al. Dendritic cells are the most efficient in presenting endogenous naturally processed self-epitopes to class II-restricted T cells. , 1995, Journal of immunology.
[71] D. Kohn,et al. Sustained human hematopoiesis in immunodeficient mice by cotransplantation of marrow stroma expressing human interleukin-3: analysis of gene transduction of long-lived progenitors. , 1994, Blood.
[72] D. Valerio,et al. Long-term expression of human adenosine deaminase in rhesus monkeys transplanted with retrovirus-infected bone-marrow cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[73] M. Colonna. Immunology: Unmasking the killer's accomplice , 1998, Nature.
[74] E. Gilboa,et al. Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo , 1996, The Journal of experimental medicine.
[75] H. Kimura,et al. A Phase III randomized study of interleukin‐2 lymphokine‐activated killer cell immunotherapy combined with chemotherapy or radiotherapy after curative or noncurative resection of primary lung carcinoma , 1997, Cancer.
[76] P. Simmons,et al. CD34 expression by stromal precursors in normal human adult bone marrow. , 1991, Blood.
[77] W. Wilmanns,et al. Donor Leukocyte Transfusions for Treatment of Recurrent Chronic Myelogenous Leukemia in Marrow Transplant Patients , 1990 .
[78] S. Rosenberg,et al. Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report. , 1988, The New England journal of medicine.
[79] J. Djeu,et al. Lysis of neuroblastoma cell lines by human natural killer cells activated by interleukin-2 and interleukin-12. , 1994, Blood.
[80] A. Lanzavecchia,et al. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation , 1996, The Journal of experimental medicine.
[81] T. Kipps,et al. Tumor necrosis factor-alpha facilitates induction of CD80 (B7-1) and CD54 on human B cells by activated T cells: complex regulation by IL-4, IL-10, and CD40L. , 1995, Cellular immunology.
[82] M. Colombo,et al. Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo , 1996, The Journal of experimental medicine.
[83] Douglas N. Rutledge,et al. Multivariate statistical analysis of two-dimensional NMR data to differentiate grapevine cultivars and clones , 1996 .
[84] S. Riddell,et al. Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis. , 1994, Blood.
[85] Dirk Schadendorf,et al. Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells , 1998, Nature Medicine.
[86] S. Lazarus,et al. High-performance liquid Chromatography/Mass spectrometry analysis of proanthocyanidins in foods and beverages. , 1999, Journal of agricultural and food chemistry.
[87] S. Steinberg,et al. Prospective randomized trial of high-dose interleukin-2 alone or in conjunction with lymphokine-activated killer cells for the treatment of patients with advanced cancer. , 1993, Journal of the National Cancer Institute.
[88] M. Atkins,et al. A randomized phase II trial of continuous infusion interleukin-2 or bolus injection interleukin-2 plus lymphokine-activated killer cells for advanced renal cell carcinoma. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[89] Emile Leporcher,et al. Deployment of Multiphase Pumps on a North Sea Field , 2001 .
[90] J. Sapis,et al. Changes and importance of oligomeric procyanidins during maturation of grape seeds , 1985 .
[91] A. Lea. Reversed-phase gradient high-performance liquid chromatography of procyanidins and their oxidation products in ciders and wines, optimised by Snyder's procedures , 1980 .
[92] D. Niederwieser,et al. Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. , 1996, Journal of immunological methods.
[93] H. Ljunggren,et al. Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy , 1986, Nature.
[94] A. Hindenburg,et al. Identification of a malignant counterpart of the monocyte-dendritic cell progenitor in an acute myeloid leukemia , 1994 .
[95] Irina Angelikadi,et al. Monitoring and controlling the biogas process , 1997 .
[96] T. Dexter. Regulation of hemopoietic cell growth and development: experimental and clinical studies. , 1989, Leukemia.
[97] D. Porter,et al. Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia. , 1994, The New England journal of medicine.
[98] J. Ozols,et al. Induction of antigen-specific cytolytic T cells in situ in human melanoma by immunization with synthetic peptide-pulsed autologous antigen presenting cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[99] A. Keating,et al. Effect of different promoters on expression of genes introduced into hematopoietic and marrow stromal cells by electroporation. , 1990, Experimental hematology.
[100] T. Whiteside,et al. Elimination of established liver metastases by human interleukin 2-activated natural killer cells after locoregional or systemic adoptive transfer. , 1996, Cancer research.
[101] C. Thompson,et al. Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation? , 1995, Cell.
[102] V. L. Singleton,et al. Isolation and Determination of Polymeric Polyphenols in Wines Using Sephadex LH-20 , 1991, American Journal of Enology and Viticulture.
[103] G. Freeman,et al. Role of B7-1 in mediating an immune response to myeloid leukemia cells. , 1995, Blood.
[104] C. Verfaillie,et al. Expansion and activation of human natural killer cells for autologous therapy. , 1994, Journal of hematotherapy.
[105] M. Albert,et al. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs , 1998, Nature.
[106] M. Williamson,et al. Structure and conformation of the procyanidin B‐2 dimer , 1997 .
[107] A. Burroughs,et al. Reconstitution of EBV-specific T cell immunity in solid organ transplant recipients. , 1998, Journal of immunology.
[108] F. Locatelli. The role of repeat transplantation of haemopoietic stem cells and adoptive immunotherapy in treatment of leukaemia relapsing following allogeneic transplantation , 1998, British journal of haematology.
[109] J. Falkenburg,et al. Generation of dendritic cells expressing bcr-abl from CD34-positive chronic myeloid leukemia precursor cells. , 1997, Human immunology.
[110] Robert H. Collins,et al. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[111] P. Hokland,et al. Natural killer cells in peripheral blood after autologous bone marrow transplantation: a combined phenotypic and functional study. , 1995, Natural immunity.
[112] T. Kipps,et al. Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal , 1993, The Journal of experimental medicine.
[113] W. Seaman,et al. A natural killer cell receptor specific for a major histocompatibility complex class I molecule , 1994, The Journal of experimental medicine.
[114] J. Falkenburg,et al. Generation of leukemia-reactive cytotoxic T lymphocyte clones from the HLA-identical bone marrow donor of a patient with leukemia , 1992, The Journal of experimental medicine.
[115] R. Steinman,et al. Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells. , 1994, The Journal of clinical investigation.
[116] A. Waterhouse,et al. Changes in grape seed polyphenols during fruit ripening. , 2000, Phytochemistry.
[117] Stephen P. A. Brown,et al. THE EFFECT OF HUMAN IL‐2‐ACTIVATED NATURAL KILLER AND T CELLS ON GRAFT‐VERSUS‐HOST DISEASE AND GRAFT‐VERSUS‐LEUKEMIA IN SCID MICE BEARING HUMAN LEUKEMIC CELLS , 1995, Transplantation.
[118] G. Pawelec,et al. BCR/ABL leukemia oncogene fusion peptides selectively bind to certain HLA-DR alleles and can be recognized by T cells found at low frequency in the repertoire of normal donors. , 1996, Blood.
[119] A. Lea. High performance liquid chromatography of cider procyanidins , 1979 .
[120] S. Gronthos,et al. The growth factor requirements of STRO-1-positive human bone marrow stromal precursors under serum-deprived conditions in vitro. , 1995, Blood.
[121] J. de Salis,et al. Multiphase Pumps for 250,000 bbl/D Field Development , 2001 .
[122] J. Hansen,et al. Alloantigen Presenting Function of Normal Human CD34+ Hematopoietic Cells , 1996 .
[123] J. McKenzie,et al. HLA-DR1-restricted bcr-abl (b3a2)-specific CD4+ T lymphocytes respond to dendritic cells pulsed with b3a2 peptide and antigen-presenting cells exposed to b3a2 containing cell lysates. , 1997, Blood.
[124] N. Frahm,et al. The defined attenuated Listeria monocytogenes Δmpl2 mutant is an effective oral vaccine carrier to trigger a long‐lasting immune response against a mouse fibrosarcoma , 1997, European journal of immunology.
[125] J. Falkenburg,et al. Recognition of clonogenic leukemic cells, remission bone marrow and HLA-identical donor bone marrow by CD8+ or CD4+ minor histocompatibility antigen-specific cytotoxic T lymphocytes. , 1995, The Journal of clinical investigation.
[126] E. Leporcher,et al. Multiphase pumping: The lessons of long-term field testing , 1995 .
[127] V. L. Singleton,et al. Isolation and Determination of Polymeric Polyphenols Using Sephadex LH-20 and Analysis of Grape Tissue Extracts , 1990 .
[128] P. Simmons,et al. Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1 , 1991 .
[129] R. Fisher,et al. Interleukin-2 and lymphokine-activated killer cell therapy of solid tumors: analysis of toxicity and management guidelines. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[130] E. Lotzová,et al. Inhibition of clonogenic growth of fresh leukemia cells by unstimulated and IL-2 stimulated NK cells of normal donors. , 1987, Leukemia research.
[131] C. Eaves,et al. Design and validation of a clinically applicable culture procedure for the generation of interleukin-2 activated natural killer cells in human bone marrow autografts. , 1993, Experimental hematology.
[132] A. Rimm,et al. Graft-versus-leukemia reactions after bone marrow transplantation. , 1990, Blood.
[133] Irini Angelidaki,et al. Codigestion of olive oil mill wastewaters with manure, household waste or sewage sludge , 1997 .
[134] D. Hanahan,et al. Modulation of L-selectin ligand expression during an immune response accompanying tumorigenesis in transgenic mice. , 1996, The Journal of clinical investigation.
[135] R. Puri,et al. In Vivo Proliferation of Adoptively Transferred Tumor‐Infiltrating Lymphocytes in Mice , 1991, Journal of immunotherapy : official journal of the Society for Biological Therapy.
[136] T. Fitzgerald,et al. Improved hematopoiesis in anemic Sl/Sld mice by splenectomy and therapeutic transplantation of a hematopoietic microenvironment. , 1989, Blood.
[137] E. Goulmy. Human minor histocompatibility antigens: new concepts for marrow transplantation and adoptive immunotherapy , 1997, Immunological reviews.
[138] E. Jaffee,et al. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. , 1994, Science.
[139] A Ferrant,et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. , 1995, Blood.
[140] R. Jain,et al. Physiologically based kinetic model of effector cell biodistribution in mammals: implications for adoptive immunotherapy. , 1996, Cancer research.
[141] R. Elashoff,et al. Prolongation of Survival in Metastatic Melanoma After Active Specific Immunotherapy With a New Polyvalent Melanoma Vaccine , 1992, Annals of surgery.
[142] A. Nagler,et al. Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation. , 1996, Blood.
[143] M. Colombo,et al. Limited antitumor T cell response in melanoma patients vaccinated with interleukin-2 gene-transduced allogeneic melanoma cells. , 1996, Human gene therapy.
[144] J. Kennedy,et al. Analysis of proanthocyanidins by high-performance gel permeation chromatography. , 2003, Journal of chromatography. A.
[145] V. Calcaterra,et al. Depletion of alloreactive T cells by a specific anti-interleukin-2 receptor p55 chain immunotoxin does not impair in vitro antileukemia and antiviral activity. , 1999, Blood.
[146] M. Horowitz,et al. Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: efficacy and toxicity of a defined T-cell dose , 1993 .
[147] S. Uchida. Condensed tannins scavenge active oxygen free radicals , 1987 .
[148] A I Caplan,et al. Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use. , 1995, Bone marrow transplantation.
[149] J. Goldman,et al. Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: the case for giving donor leukocyte transfusions before the onset of hematologic relapse. , 1994, Blood.
[150] R. Levy,et al. Idiotype/granulocyte-macrophage colony-stimulating factor fusion protein as a vaccine for B-cell lymphoma , 1993, Nature.
[151] J. Goldman,et al. The rate and kinetics of molecular response to donor leucocyte transfusions in chronic myeloid leukaemia patients treated for relapse after allogeneic bone marrow transplantation , 1997, British journal of haematology.
[152] L. Kanz,et al. Generation of antigen‐presenting cells for soluble protein antigens ex vivo from peripheral blood CD34+ hematopoietic progenitor cells in cancer patients , 1996, European journal of immunology.
[153] M. Colombo,et al. Granulocyte colony-stimulating factor gene transfer suppresses tumorigenicity of a murine adenocarcinoma in vivo , 1991, The Journal of experimental medicine.
[154] H. L. Longworth,et al. Underground Disposal of Acid Gas in Alberta, Canada: Regulatory Concerns and Case Histories , 1996 .
[155] E. Gilboa,et al. Induction of antitumor immunity using bone marrow-generated dendritic cells. , 1996, Journal of immunology.
[156] D. Huhn,et al. Propagation of large numbers of T cells with natural killer cell markers , 1994, British journal of haematology.
[157] R. Steinman,et al. Dendritic cells stimulate primary human cytolytic lymphocyte responses in the absence of CD4+ helper T cells , 1990, The Journal of experimental medicine.
[158] N. Hensel,et al. Preferential usage of T cell receptor (TCR) V β by allogeneic T cells recognizing myeloid leukemia cells: implications for separating graft-versus-leukemia effect from graft-versus-host disease , 1997, Bone Marrow Transplantation.
[159] S. Rosenberg,et al. Interferon gamma and tumor necrosis factor have a role in tumor regressions mediated by murine CD8+ tumor-infiltrating lymphocytes , 1991, The Journal of experimental medicine.
[160] H. Broxmeyer,et al. Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. , 1980, Blood.
[161] A. Sette,et al. Specific human cellular immunity to bcr-abl oncogene-derived peptides. , 1996, Blood.
[162] S. Singhal,et al. Outcome of acute leukemia relapsing after bone marrow transplantation: utility of second transplants and adoptive immunotherapy , 1997, Bone Marrow Transplantation.
[163] J. Schlom,et al. Therapeutic antitumor response after immunization with an admixture of recombinant vaccinia viruses expressing a modified MUC1 gene and the murine T-cell costimulatory molecule B7. , 1997, Journal of immunotherapy.
[164] R. Goldfarb,et al. Localization of immune effector cells to tumor metastases. , 1994, Immunology series.
[165] C. Bordignon,et al. Peripheral Blood Lymphocytes as Target Cells of Retroviral Vector-Mediated Gene Transfer , 1994 .
[166] Baoshan Sun,et al. Separation of Grape and Wine Proanthocyanidins According to Their Degree of Polymerization , 1998 .
[167] R. Steinman,et al. Dendritic cells pulsed with protein antigens in vitro can prime antigen- specific, MHC-restricted T cells in situ [published erratum appears in J Exp Med 1990 Oct 1;172(4):1275] , 1990, The Journal of experimental medicine.
[168] G. Keller,et al. Generation of purified stromal cell cultures that support lymphoid and myeloid precursors. , 1986, Journal of immunological methods.
[169] Richard A. Flavell,et al. Help for cytotoxic-T-cell responses is mediated by CD40 signalling , 1998, Nature.
[170] R. Newman,et al. Polymeric proanthocyanidins. Stereochemistry, structural units, and molecular weight , 1981 .
[171] Y. Glories,et al. Characterisation of oligomeric and polymeric procyanidins from grape seeds by liquid secondary ion mass spectrometry , 1998 .
[172] S. Riddell,et al. Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease. , 1991, Blood.
[173] H. Heslop,et al. Donor T cells to treat EBV-associated lymphoma. , 1994, The New England journal of medicine.
[174] L. Lanier,et al. Inhibitory MHC class I receptors on NK cells and T cells. , 1996, Immunology today.
[175] R. Jain,et al. Low deformability of lymphokine-activated killer cells as a possible determinant of in vivo distribution. , 1989, Cancer research.
[176] R. Schwartz,et al. Models of T Cell Anergy: Is There a Common Molecular Mechanism? , 1996 .
[177] D. Fitzpatrick,et al. Isolation and characterization of endothelium-dependent vasorelaxing compounds from grape seeds. , 2000, Journal of agricultural and food chemistry.
[178] F. Locatelli,et al. Alloantigen-induced human lymphocytes rendered nonresponsive by a combination of anti-CD80 monoclonal antibodies and cyclosporin-A suppress mixed lymphocyte reaction in vitro. , 1995, Journal of immunology.
[179] Polly Matzinger,et al. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell , 1998, Nature.
[180] A. Friedenstein,et al. THE DEVELOPMENT OF FIBROBLAST COLONIES IN MONOLAYER CULTURES OF GUINEA‐PIG BONE MARROW AND SPLEEN CELLS , 1970, Cell and tissue kinetics.
[181] J. M. D. Silva,et al. Catechin and procyanidin composition of seeds from grape cultivars grown in Ontario. , 1997 .
[182] R. Levy,et al. Idiotype vaccination against murine B cell lymphoma. Humoral and cellular requirements for the full expression of antitumor immunity. , 1990, Journal of immunology.
[183] A. Waterhouse,et al. A Comparison of Methods For Quantifying Oligomeric Proanthocyanidins From Grape Seed Extracts , 2000, American Journal of Enology and Viticulture.
[184] R. Steinman,et al. The endocytic activity of dendritic cells , 1995, The Journal of experimental medicine.
[185] K. Dorshkind,et al. B lymphocyte precursors and myeloid progenitors survive in diffusion chamber cultures but B cell differentiation requires close association with stromal cells. , 1987, Blood.
[186] R. Motzer,et al. Phase iii randomized trial of interleukin‐2 with or without lymphokine‐activated killer cells in the treatment of patients with advanced renal cell carcinoma , 1995, Cancer.
[187] S. Rosenberg,et al. Antibody-dependent cellular cytotoxicity mediated by murine lymphocytes activated in recombinant interleukin 2. , 1987, Journal of immunology.
[188] B. Bogen,et al. Clonal deletion of thymocytes as a tumor escape mechanism , 1998, International journal of cancer.
[189] A. Perelson,et al. Nonlinear dynamics of immunogenic tumors: parameter estimation and global bifurcation analysis. , 1994, Bulletin of mathematical biology.
[190] P. Reinert,et al. Successful engraftment after autologous transplantation of 10-day cultured bone marrow activated by interleukin 2 in patients with acute lymphoblastic leukemia. , 1995, Bone Marrow Transplantation.
[191] D. Carbone,et al. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells , 1996, Nature Medicine.
[192] M. Caligiuri,et al. Role of interleukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells. , 1996, Blood.
[193] R. Foà,et al. Cytotoxic effectors activated by low‐dose IL‐2 plus IL‐12 lyse IL‐2‐resistant autologous acute myeloid leukaemia blasts , 1998, British journal of haematology.
[194] A. Harris,et al. Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer. , 1996, British Journal of Cancer.
[195] R. Cameron,et al. Effect of combined therapy with lymphokine-activated killer cells, interleukin 2 and specific monoclonal antibody on established B16 melanoma lung metastases. , 1988, Cancer research.
[196] E. Waters,et al. Quantitative analysis of polymeric procyanidins (Tannins) from grape (Vitis vinifera) seeds by reverse phase high-performance liquid chromatography. , 2001, Journal of agricultural and food chemistry.
[197] S M Larson,et al. Tumor localization of adoptively transferred indium-111 labeled tumor infiltrating lymphocytes in patients with metastatic melanoma. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[198] A. Toubert,et al. Human leukemia-derived dendritic cells: ex-vivo development of specific antileukemic cytotoxicity. , 1998, Critical reviews in immunology.
[199] P. Bruggen,et al. Human tumor antigens recognized by T lymphocytes , 1996, The Journal of experimental medicine.
[200] Johan,et al. Functional expression of adhesion receptors and costimulatory molecules by fresh and immortalized B-cell non-Hodgkin's lymphoma cells. , 1995, Blood.
[201] R. Steinman,et al. Small amounts of superantigen, when presented on dendritic cells, are sufficient to initiate T cell responses , 1993, The Journal of experimental medicine.
[202] A. Cheminat,et al. Procyanidin dimers and trimers from grape seeds , 1991 .
[203] S Kimbrough,et al. Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the treatment of patients with EBV-positive relapsed Hodgkin's disease. , 1998, Blood.
[204] Celestino Santos-Buelga,et al. Proanthocyanidins and tannin‐like compounds – nature, occurrence, dietary intake and effects on nutrition and health , 2000 .
[205] Jean Falcimaigne,et al. Multiphase Rotodynarnic Pumps Extend their Operating Capabilities , 1994 .
[206] J. Gribben,et al. Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[207] B. Gabetta,et al. Characterization of proanthocyanidins from grape seeds. , 2000, Fitoterapia.
[208] S. Riddell,et al. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. , 1995, The New England journal of medicine.
[209] R. Gale,et al. Abnormalities of myeloid progenitor cells after "successful" bone marrow transplantation. , 1985, The Journal of clinical investigation.
[210] J. Griffin. Hemopoietins in oncology: factoring out myelosuppression. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[211] D. Niederwieser,et al. Dendritic cells generated from blood precursors of chronic myelogenous leukemia patients carry the philadelphia translocation and can induce a CML‐specific primary cytotoxic T‐cell response , 1997, Genes, chromosomes & cancer.
[212] T. Reynolds,et al. T–cell mediated rejection of gene–modified HIV–specific cytotoxic T lymphocytes in HIV–infected patients , 1996, Nature Medicine.
[213] G. Freeman,et al. B7-1 is superior to B7-2 costimulation in the induction and maintenance of T cell-mediated antileukemia immunity. Further evidence that B7-1 and B7-2 are functionally distinct. , 1996, Journal of immunology.
[214] D. Kufe,et al. Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells , 1997, Nature Medicine.
[215] M. Rosenzwajg,et al. Human dendritic cell differentiation pathway from CD34+ hematopoietic precursor cells. , 1996, Blood.
[216] J. Szer,et al. Bone marrow stromal function from patients after bone marrow transplantation. , 1995, Bone marrow transplantation.
[217] J. Mier,et al. Laboratory correlates of adoptive immunotherapy with recombinant interleukin-2 and lymphokine-activated killer cells in humans. , 1988, Cancer research.
[218] S. Gerson,et al. Phenotypic and functional comparison of cultures of marrow‐derived mesenchymal stem cells (MSCs) and stromal cells , 1998, Journal of cellular physiology.
[219] C. Rinaldo,et al. HLA-restricted lysis of herpes simplex virus-infected monocytes and macrophages mediated by CD4+ and CD8+ T lymphocytes. , 1989, Journal of immunology.
[220] M. Colombo,et al. Interferon γ–independent Rejection of Interleukin 12–transduced Carcinoma Cells Requires CD4+ T Cells and Granulocyte/Macrophage Colony–stimulating Factor , 1998, The Journal of Experimental Medicine.
[221] F. Prósper,et al. Natural killer (NK) cells are functionally abnormal and NK cell progenitors are diminished in granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cell collections. , 1997, Blood.
[222] P. Ricciardi-Castagnoli,et al. Bacteria-induced neo-biosynthesis, stabilization, and surface expression of functional class I molecules in mouse dendritic cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[223] S. Gronthos,et al. The biology and application of human bone marrow stromal cell precursors. , 1996, Journal of hematotherapy.
[224] K. Kliche,et al. Use of leukemic dendritic cells for the generation of antileukemic cellular cytotoxicity against Philadelphia chromosome-positive chronic myelogenous leukemia. , 1997, Blood.
[225] T. Starzl,et al. Autologous lymphokine-activated killer cell therapy of Epstein-Barr virus-positive and -negative lymphoproliferative disorders arising in organ transplant recipients. , 1997, Transplantation.
[226] P. Colombat,et al. Haemopoiesis of transplanted patients with autologous marrows assessed by long‐term marrow culture , 1994, British journal of haematology.
[227] H. Bear,et al. Inhibition of tumor-specific cytotoxic T-lymphocyte responses by transforming growth factor beta 1. , 1992, Cancer research.
[228] V. Cheynier,et al. Oligomeric and polymeric procyanidins from grape seeds. , 1994 .
[229] S. Rosenberg,et al. In vivo antitumor activity of tumor-infiltrating lymphocytes expanded in recombinant interleukin-2. , 1987, Journal of the National Cancer Institute.
[230] K. Dorshkind,et al. Pre-B cell generation potentiated by soluble factors from a bone marrow stromal cell line. , 1988, Journal of immunology.
[231] C. Anasetti,et al. Expression of CD86 on Human Marrow CD34+ Cells Identifies Immunocompetent Committed Precursors of Macrophages and Dendritic Cells , 1998 .
[232] S. Rosenberg. Lymphokine-activated killer cells: a new approach to immunotherapy of cancer. , 1985, Journal of the National Cancer Institute.
[233] Jon Arve Svaeren,et al. Application and Status of New Building Blocks for Subsea Boosting and Processing Systems , 2000 .
[234] Hervé Groux,et al. A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis , 1997, Nature.
[235] R. Giavazzi,et al. Transfer of the HSV-tk gene into donor peripheral blood lymphocytes for in vivo modulation of donor anti-tumor immunity after allogeneic bone marrow transplantation. , 1995, Human gene therapy.
[236] T. Nose,et al. Induction of human autologous cytotoxic T lymphocytes against minced tissues of glioblastoma multiforme. , 1996, Journal of neurosurgery.
[237] F. Sallusto,et al. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha , 1994, The Journal of experimental medicine.
[238] S. Perkins,et al. Hematopoietic microenvironment. Origin, lineage, and transplantability of the stromal cells in long-term bone marrow cultures from chimeric mice. , 1988, The Journal of clinical investigation.